Anatara Lifesciences trading on ASX
Anatara Lifesciences has listed on the ASX following its $7 million IPO. The shares started trading today under the ticker code ANR.
Anatara closed its oversubscribed IPO last week to help raise funds for the commercial development of non-antibiotic diarrhoea therapy Detach. The shares were priced at $0.50.
The company is focused on commercialising Detach in pigs first, and plans to use part of the proceeds to fund registration of the product for use in pigs in Australia, the EU and the US.
More long-term plans include expanding its use to other livestock and developing a version for human applications.
“This is an exciting day for Anatara as we take our first steps as a public company addressing an unmet need for effective non-antibiotic treatments and medicines,” Anatara Chairman Dr Mel Bridges said.
“We look forward to updating shareholders on our progress with Detach and seeing this important and innovative product enter the market.”
Anatara Lifesciences (ASX:ANR) shares were trading at 0.375 as of around 1.30 pm on Thursday.
'Low-risk' antibiotic linked to rise of dangerous superbug
A new study has challenged the long-held belief that rifaximin — commonly prescribed to...
Robotic hand helps cultivate baby corals for reef restoration
The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating...
Stem cell experiments conducted in space
Scientists are one step closer to manufacturing stem cells in space — which could speed up...
